Beijing Strong Biotechnologies, Inc. (300406.SZ): Thyroxine-binding test kit obtained a medical device registration certificate.
Jiuqiang Biology (300406.SZ) announced that the company recently received the Medical Device Registration Certificate for Thyroxine Binding Capacity Test Kit (Magnetic Chemiluminescence Immunoassay) issued by the Beijing Municipal Drug Administration. This test kit is used for in vitro quantitative determination of thyroid hormone binding capacity (T-Uptake) in human serum or plasma.
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that the company recently received the Medical Device Registration Certificate for the Thyroxine Binding Capacity Detection Kit (Chemiluminescent Immunoassay using Magnetic Micro-particles) from the Beijing Drug Administration. This test kit is used for in vitro quantitative determination of thyroxine binding capacity (T-Uptake) in human serum or plasma.
The acquisition of this medical device registration certificate enriches the variety of products in the company's in vitro diagnostic chemiluminescence subdivision field, which is beneficial for further enhancing the company's core competitiveness and market expansion capabilities. This will have a positive impact on the company's future operations.
Related Articles

HUABAO INTL (00336) announced on June 3 that it repurchased 550,000 shares for HK$2.057 million.

On June 3rd, CHINA STARCH (03838) spent 264,300 Hong Kong dollars to repurchase 1.57 million shares.

LX TECHNOLOGY (02436) spent HK$134,500 to repurchase 5,400 shares on June 3rd.
HUABAO INTL (00336) announced on June 3 that it repurchased 550,000 shares for HK$2.057 million.

On June 3rd, CHINA STARCH (03838) spent 264,300 Hong Kong dollars to repurchase 1.57 million shares.

LX TECHNOLOGY (02436) spent HK$134,500 to repurchase 5,400 shares on June 3rd.






